4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-024893
SVP and General Counsel sold 4,167 shares at $40.00 ($166,680)
- SVP and General Counsel acquired 4,167 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2021-03-31 | Option exercise | +1,042 | $7.80 | $8,128 | 16,078 | D |
| Taylor Stacy L SVP and General Counsel | 2021-03-31 | Option exercise | +1,771 | $6.55 | $11,600 | 17,849 | D |
| Taylor Stacy L SVP and General Counsel | 2021-03-31 | Option exercise | +1,354 | $31.71 | $42,935 | 19,203 | D |
| Taylor Stacy L SVP and General Counsel | 2021-03-31 | Sale | −4,167 | $40.00 | $166,680 | 15,036 | D |
| Derivatives | |||||||
| Taylor Stacy L SVP and General Counsel | 2021-03-31 | Option exercise · Stock Option (Right to Buy) | −1,042 | 26,042 | D | ||
| Taylor Stacy L SVP and General Counsel | 2021-03-31 | Option exercise · Stock Option (Right to Buy) | −1,771 | 21,250 | D | ||
| Taylor Stacy L SVP and General Counsel | 2021-03-31 | Option exercise · Stock Option (Right to Buy) | −1,354 | 47,396 | D | ||
| Open-market sales · 4,167 sh · avg $40.00 · $166,680 | |||||||
Loading xslF345X03/doc4.xml…